{"transactions":[{"id":874855,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":64023,"kind":"person","name":"Boyd Taylor","position":1,"cik":"0002090172","reported_name":"Boyd Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-02T16:22:37.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests twenty-five percent (25%) on February 26, 2027 and the remainder will vest in equal monthly installments over the following three (3) years, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":95000,"derivative":{"exercise_price":17.64,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0002090172-26-000002","document":"form4-03022026_090334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2090172/000209017226000002/form4-03022026_090334.xml","form_type":"4"}},{"id":1023536,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":64023,"kind":"person","name":"Boyd Taylor","position":1,"cik":"0002090172","reported_name":"Boyd Taylor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-06T16:28:32.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was granted on October 1, 2025, and vests over four years, with the first 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments over the following three years, subject to the reporting person's continued employment with the Company on each applicable vesting date."}],"balance_after":275000,"derivative":{"exercise_price":12.96,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0002090172-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2090172/000209017225000002/primary_doc.xml","form_type":"4"}}]}